Welcome to LookChem.com Sign In|Join Free

CAS

  • or

52514-63-3

Post Buying Request

52514-63-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

52514-63-3 Usage

Description

C11H16N2O4, also known as (S)-Carbidopa Methyl Ester, is an S-isomer prodrug of Carbidopa (C175915(M)), an inhibitor of aromatic amino acid decarboxylase. It is a compound with a molecular structure consisting of 11 carbon atoms, 16 hydrogen atoms, 2 nitrogen atoms, and 4 oxygen atoms.

Uses

Used in Pharmaceutical Industry:
C11H16N2O4 is used as a prodrug for [application reason] in the pharmaceutical industry. As an S-isomer prodrug of Carbidopa, it serves to enhance the bioavailability and effectiveness of the parent drug, Carbidopa, which is an inhibitor of aromatic amino acid decarboxylase. This inhibition helps regulate the levels of neurotransmitters in the brain, making it useful in the treatment of various neurological disorders.
Used in Parkinson's Disease Treatment:
C11H16N2O4 is used as a therapeutic agent for the treatment of Parkinson's disease. As a prodrug of Carbidopa, it helps to increase the availability of levodopa, a drug used to treat Parkinson's disease, by inhibiting its peripheral decarboxylation. This results in a more controlled and sustained release of levodopa, reducing the side effects and improving the overall treatment outcome for patients with Parkinson's disease.

Check Digit Verification of cas no

The CAS Registry Mumber 52514-63-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,5,1 and 4 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 52514-63:
(7*5)+(6*2)+(5*5)+(4*1)+(3*4)+(2*6)+(1*3)=103
103 % 10 = 3
So 52514-63-3 is a valid CAS Registry Number.

52514-63-3Downstream Products

52514-63-3Relevant articles and documents

L-DOPA AND/OR DOPA DECARBOXYLSE INHIBITORS CONJUGATED TO SUGAR FOR THE TREATMENT OF DOPAMINE-RESPONSIVE DISORDERS

-

Paragraph 00238; 00239; 00240, (2020/07/05)

The present invention provides conjugates comprising a sugar such as mannitol and one or more L-DOPA and/or DOPA decarboxylse inhibitors including, inter alia, L- DOPA, carbidopa, benserazide, or a combination thereof, wherein the sugar is conjugated to t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 52514-63-3